Ameritas Investment Partners, Inc. Haemonetics Corp Transaction History

Ameritas Investment Partners, Inc.

$2.84 Billion
Q2 2024

A detailed history of Ameritas Investment Partners, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 15,805 shares of HAE stock, worth $1.26 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

15,805

Previous 16,207 2.48%

Holding current value

$1.26 Million

Previous $1.38 Million 5.5%

% of portfolio

0.05%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$81.24 - $97.37 $32,658 - $39,142	-402 Reduced 2.48%	15,805 $1.31 Million
Q1 2024 May 13, 2024	SELL	$71.24 - $85.35 $13,535 - $16,216	-190 Reduced 1.16%	16,207 $1.38 Million
Q4 2023 Feb 14, 2024	BUY	$80.59 - $92.61 $3,143 - $3,611	39 Added 0.24%	16,397 $1.4 Million
Q3 2023 Nov 13, 2023	SELL	$82.56 - $93.49 $31,620 - $35,806	-383 Reduced 2.29%	16,358 $1.47 Million
Q2 2023 Aug 11, 2023	SELL	$80.84 - $89.45 $6,790 - $7,513	-84 Reduced 0.5%	16,741 $1.43 Million
Q1 2023 May 10, 2023	SELL	$72.75 - $90.6 $25,753 - $32,072	-354 Reduced 2.06%	16,825 $1.39 Million
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $8,229 - $10,225	-130 Reduced 0.75%	17,179 $1.27 Million
Q2 2022 Aug 12, 2022	SELL	$49.27 - $66.08 $7,242 - $9,713	-147 Reduced 0.84%	17,309 $1.13 Million
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $30,700 - $37,624	-533 Reduced 2.96%	17,456 $1.23 Million
Q2 2021 Aug 06, 2021	BUY	$51.81 - $118.56 $204,960 - $469,023	3,956 Added 28.19%	17,989 $1.2 Million
Q4 2020 Feb 12, 2021	SELL	$88.75 - $119.95 $28,400 - $38,384	-320 Reduced 2.23%	14,033 $1.67 Million
Q3 2020 Nov 13, 2020	SELL	$75.65 - $93.58 $16,945 - $20,961	-224 Reduced 1.54%	14,353 $1.25 Million
Q2 2020 Aug 05, 2020	SELL	$84.96 - $118.91 $340,944 - $477,185	-4,013 Reduced 21.59%	14,577 $1.31 Million
Q1 2020 May 13, 2020	SELL	$74.34 - $121.82 $7,359 - $12,060	-99 Reduced 0.53%	18,590 $1.85 Million
Q4 2019 Feb 13, 2020	BUY	$114.37 - $129.46 $2,516 - $2,848	22 Added 0.12%	18,689 $2.15 Million
Q3 2019 Nov 14, 2019	SELL	$117.16 - $138.52 $67,367 - $79,649	-575 Reduced 2.99%	18,667 $2.36 Million
Q1 2019 May 15, 2019	SELL	$83.25 - $102.12 $29,054 - $35,639	-349 Reduced 1.78%	19,242 $1.68 Million
Q4 2018 Feb 12, 2019	BUY	$90.66 - $116.63 $12,692 - $16,328	140 Added 0.72%	19,591 $1.96 Million
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $33,285 - $42,394	-370 Reduced 1.87%	19,451 $2.23 Million
Q2 2018 Aug 13, 2018	BUY	$71.53 - $95.75 $1.09 Million - $1.46 Million	15,273 Added 335.82%	19,821 $1.78 Million
Q1 2018 May 15, 2018	BUY	$60.72 - $74.41 $7,832 - $9,598	129 Added 2.92%	4,548 $333,000
Q2 2017 Aug 15, 2017	BUY	N/A	4,419	4,419 $175,000

Others Institutions Holding HAE

# of Institutions

337

Shares Held

55.2M

Call Options Held

383K

Put Options Held

45.1K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.1B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Account

Ameritas Investment Partners, Inc. Haemonetics Corp Transaction History